Farid El Oualid received his PhD in Bioorganic Chemistry in 2005 from Leiden University. After his PhD, Farid performed post-doctoral research at Oxford University and it was during this period that he started getting interested in the emerging Ubiquitin Proteasome Field. In 2008 he joined the Netherlands Cancer Institute where he focused on the development of chemical technologies for ubiquitin(-like protein) based research tools. Based on this, he co-founded UbiQ in 2010 where he is responsible for general lab management and product development. In January 2017 he co-founded SumiQ as CSO of UbiQ.